Literature DB >> 16539276

Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis.

T S Han1, M M Schwartz, E J Lewis.   

Abstract

We investigated a series of patients with systemic lupus erythematosus (SLE), who had sparse subepithelial and mesangial immune deposits. Our goal was to determine structure: function correlation. We examined whether proteinuria correlated with either capillary wall immune aggregate formation or abnormal podocyte morphology. Renal biopsies from patients with sparse (two or fewer subepithelial or intramembranous electron dense deposits per glomerular capillary loop) immune deposits and podocyte effacement were studied. Patients fulfilled criteria for the diagnosis of SLE. Cases were excluded if the biopsy showed endocapillary proliferation or necrosis. Eighteen biopsies were studied, five from patients with nephrotic range proteinuria (> or =3 g/day) and 13 from patients with non-nephrotic proteinuria (<3 g/day). The five nephrotic patients had a mean foot process effacement of 48% +/- 39% (range 10-100%). Thirteen non-nephrotic patients had a mean foot process effacement of 11.7% +/- 8% (range 0-20%). The only distinguishing morphologic finding associated with nephrotic range proteinuria was diffuse foot process effacement. No correlation between subepithelial deposits and proteinuria was observed. There were no other histologic differences between the nephrotic and non-nephrotic patients. Among these patients, the nephrotic syndrome appears best correlated with podocytopathy rather than subepithelial electron dense deposits, mesangial deposits, or mesangial hypercellularity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16539276     DOI: 10.1191/0961203306lu2264oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  Unique microstructures and podocytic infolding in glomerular basement membrane associated with collagen diseases: a report of three cases.

Authors:  Hitoshi Sugiyama; Mie Maruyama; Hiroshi Morinaga; Tatsuyuki Inoue; Kei-Ichi Takiue; Yoko Kikumoto; Masaru Kinomura; Ken-Ei Sada; Shigeru Akagi; Shinji Kitamura; Yohei Maeshima; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2008-10-08       Impact factor: 2.801

Review 2.  Immunopathology of lupus nephritis.

Authors:  Hans-Joachim Anders; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2014-01-09       Impact factor: 9.623

Review 3.  Lupus podocytopathy: a distinct entity of lupus nephritis.

Authors:  Duqun Chen; Weixin Hu
Journal:  J Nephrol       Date:  2017-12-22       Impact factor: 3.902

Review 4.  Autoreactive B cells in SLE, villains or innocent bystanders?

Authors:  Jennie A Hamilton; Hui-Chen Hsu; John D Mountz
Journal:  Immunol Rev       Date:  2019-10-21       Impact factor: 12.988

5.  Clinical-Morphological Features and Outcomes of Lupus Podocytopathy.

Authors:  Weixin Hu; Yinghua Chen; Shaofan Wang; Hao Chen; Zhengzhao Liu; Caihong Zeng; Haitao Zhang; Zhihong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-16       Impact factor: 8.237

6.  Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.

Authors:  Mariane dos Santos; Rafael N Bringhenti; Patrícia G Rodrigues; Jonathan F do Nascimento; Sane V Pereira; Rafael Zancan; Odirlei A Monticielo; Andrese A Gasparin; Waldir P de Castro; Francisco V Veronese
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene.

Authors:  Chinedu Njoku; Sally E Self; Philip Ruiz; Ann F Hofbauer; Gary S Gilkeson; Jim C Oates
Journal:  J Investig Med       Date:  2008-10       Impact factor: 2.895

8.  Increased excretion of urinary podocytes in lupus nephritis.

Authors:  J J Bollain-Y-Goytia; M González-Castañeda; F Torres-Del-Muro; L Daza-Benitez; P Zapata-Benavides; C Rodríguez-Padilla; E Avalos-Díaz; R Herrera-Esparza
Journal:  Indian J Nephrol       Date:  2011-07

9.  Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis.

Authors:  Ashley J Snider; Phillip Ruiz; Lina M Obeid; Jim C Oates
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

10.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.